Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL45577 | 1.00 | ALDH1A1 (0.32) | ALDH1A1TSHRFGFR4TDP1LMNA | |
| SCHEMBL1201121 | 0.84 | TDP1 (0.38) | ALDH1A1TSHRFGFR4TDP1LMNA | |
| SCHEMBL1635822 | 0.84 | TDP1 (0.38) | ALDH1A1TSHRFGFR4TDP1LMNA | |
| SCHEMBL8927707 | 0.78 | FNTA (0.34) | TDP1 | |
| SCHEMBL14938405 | 0.77 | — | — | |
| SCHEMBL18755191 | 0.77 | ALDH1A1 (0.30) | ALDH1A1TSHRFGFR4 | |
| SCHEMBL517190 | 0.76 | ALDH1A1 (0.35) | ALDH1A1LMNA | |
| SCHEMBL8760513 | 0.76 | ALDH1A1 (0.35) | ALDH1A1TSHRFGFR4LMNA | |
| SCHEMBL8944182 | 0.76 | ALDH1A1 (0.35) | ALDH1A1LMNA | |
| SCHEMBL362181 | 0.76 | ALDH1A1 (0.35) | ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013054352-A1 | PHARMACEUTICAL COMPOSITIONS OF IBUPROFEN AND FAMOTIDINE | CADILA HEALTHCARE LIMITED (IN) | 2013-04-18 | — | — | WO | claimed |
| EP-1694303-A1 | TASTE MASKED PHARMACEUTICAL COMPOSITION COMPRISING PH SENSITIVE POLYMER | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2006-08-30 | — | — | EP | claimed |
| WO-2005055986-A1 | TASTE MASKED PHARMACEUTICAL COMPOSITION COMPRISING PH SENSITIVE POLYMER | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2005-06-23 | — | — | WO | claimed |
| US-20050136115-A1 | Taste masked pharmaceutical composition comprising pH sensitive polymer | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2005-06-23 | — | — | US | claimed |
| EP-1131057-B1 | CUSHIONING WAX BEADS FOR MAKING SOLID SHAPED ARTICLES | UNIV GENT (BE) | 2005-04-20 | — | — | EP | claimed |
| US-11786476-B2 | Oral dosage form | UNIVERSITEIT GENT (BE) | 2023-10-17 | — | — | US | disclosed |
| US-20220339857-A1 | 3D PRINTING DEVICE AND METHOD | Triastek, Inc. (CN) | 2022-10-27 | — | — | US | disclosed |
| US-11364674-B2 | 3D printing device and method | Triastek, Inc. (CN) | 2022-06-21 | — | — | US | disclosed |
| US-20210353548-A1 | ORAL DOSAGE FORM | UNIVERSITEIT GENT (BE) | 2021-11-18 | — | — | US | disclosed |
| EP-3892263-A1 | ORAL DOSAGE FORM | Universiteit Gent (BE) | 2021-10-13 | — | — | EP | disclosed |
| US-11065207-B2 | Oral dosage form | UNIVERSITEIT GENT (BE) | 2021-07-20 | — | — | US | disclosed |
| US-20210154910-A1 | 3D PRINTING DEVICE AND METHOD | Triastek, Inc. (CN) | 2021-05-27 | — | — | US | disclosed |
| WO-2008011426-A2 | METHODS AND MEDICAMENTS FOR ADMINISTRATION OF IBUPROFEN | HORIZON THERAPEUTICS, INC. (US) | 2008-01-24 | — | — | WO | disclosed |
| US-20080021078-A1 | Methods and medicaments for administration of ibuprofen | HORIZON THERAPEUTICS, INC. (US) | 2008-01-24 | — | — | US | disclosed |
| CN-1221281-C | Oral, nasal and pulmonary dosage formulations of copolymer1 | YEDA RES & DEV (IL) | 2005-10-05 | — | — | CN | disclosed |
| CN-1424915-A | Oral, nasal and pulmonary dosage formulations of copolymer1 | YEDA RES DEV CO LTD AT THE WEI (IL) | 2003-06-18 | — | — | CN | disclosed |
| US-6379706-B2 | WHICH CONTAIN AT LEAST ONE ROUNDING AGENT REQUIRED TO PRODUCE EXTRUSION PELLETS WHICH ACTS AS A RETARDANT OR DISINTEGRATION-RETARDING AGENT WHICH IS SUITABLE FOR DELAYING THE RELEASE TIME OF ACTIVE SUBSTANCES | ROCHE DIAGNOSTICS GMBH (DE) | 2002-04-30 | — | — | US | disclosed |
| WO-2002017877-A2 | CONTROLLED RELEASE PHARMACEUTICAL PELLET COMPOSITIONS FOR REDUCING SIDE EFFECTS OF DRUGS | UNIVERSITEIT GENT (BE) | 2002-03-07 | — | — | WO | disclosed |
| US-20010004458-A1 | Rapidly disintegrating pellets | ROCHE DIAGNOSTICS GMBH | 2001-06-21 | — | — | US | disclosed |
| US-6224909-B1 | DRUG MIXTURE OF ACTIVE MATERIALS, RELEASE RETARDERS, TABLET DISINTEGRANT, SURFACTANT AND BINDER | ROCHE DIAGNOSTICS GMBH (DE) | 2001-05-01 | — | — | US | disclosed |